Navigation Links
Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate
Date:10/9/2008

Researchers at the European Molecular Biology Laboratory (EMBL) have generated a digital zebrafish embryo - the first complete developmental blueprint of a vertebrate. With a newly developed microscope scientists could for the first time track all cells for the first 24 hours in the life of a zebrafish. The data was reconstructed into a three-dimensional, digital representation of the embryo. The study, published in the current online issue of Science, grants many new insights into embryonic development. Movies of the digital embryo and the underlying database of millions of cell positions, divisions and tracks will be made publicly available to provide a novel resource for research and scientific training.

To get from one cell to a complex organism, cells have to divide, travel around the body and arrange intricate shapes and specialized tissues. The best way to understand these dynamic processes is to look at what happens in the first few hours of life in every part of an embryo. While this is possible with invertebrates with a few hundred cells, like worms for example, it has so far been impossible to achieve for vertebrates.

"Imagine following all inhabitants of a town over the course of one day using a telescope in space. This comes close to tracking the 10 thousands of cells that make up a vertebrate embryo only that the cells move in three dimensions," says Philipp Keller. Together with Annette Schmidt he carried out the research in the labs of Jochen Wittbrodt and Ernst Stelzer at EMBL.

Two newly developed technologies were key to the scientists' interdisciplinary approach to tracking a living zebrafish embryo from the single cell stage to 20,000 cells: a Digital Scanned Laser Light Sheet Microscope, that scans a living organism with a sheet of light along many different directions so that the computer can assemble a complete 3D image, and a large-scale computing pipeline operated at the Karlsruhe Institute of Te
'/>"/>

Contact: Anna-Lynn Wegener
wegener@embl.de
49-622-138-7452
European Molecular Biology Laboratory
Source:Eurekalert  

0

GOOD

Page: 1 2

Related biology news :

1. Entrust Digital Signatures Help Secure More Than 18 Million U.S. ePassports
2. Book is the first high-resolution digital mouse brain atlas designed for Web applications
3. FEBS Letters Structured Digital Abstracts experiment
4. Vobile Launches VideoDNA Live; Enables Real-Time Digital Content Protection for Live Broadcast Events
5. Fixing the education digital disconnect one video game at a time
6. Digital cameras, remote satellites measure crop water demand
7. Zebrafish to shed light on human mitochondrial diseases
8. Study shows how the zebrafish gets his stripe
9. A screening strategy using zebrafish targets genes that protect against hearing loss
10. Deadly genetic disease prevented before birth in zebrafish
11. Scientists identify embryonic stem cells by appearance alone

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate
Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate
(Date:11/4/2009)...t,s the cost of saving a teenage life? When it com...rescription medication abuse, there,s no price tag...aware that the lock-boxes they,ve installed are no... of prescription drugs. That,s why MEDNET(TM), a n..., has formed an exclusive partnership with Axius H...
(Date:11/4/2009)...l/ -- BIO-key International, Inc. (OTC Bulletin Bo...ntification software is showcasing donor and patie...being held at the New Orleans Convention Center fr...on product demonstrations of its state-of-the-art ...5 PM on Monday, October 26, Peter Lux, manager of ...
(Date:11/4/2009)...sity of North Carolina at Chapel Hill School of Me...isco have developed and experimentally tested a te...g drugs. , The researchers developed a computati...es of all known drugs are to the naturally occurri...ase targets within the cell. In a study published ...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Study points to new uses, unexpected side effects of already existing drugs 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 1Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 2Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 3Worlds First Emergency Medical Information Franchise Launches GPS Tracking Device 57337 4Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 1Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 2Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 3Keryx Biopharmaceuticals Receives Orphan Drug Designation for KRX 0401 28Perifosine 29 for the Treatment of Multiple Myeloma 57335 4
...erta has helped map out the animal,s life span and...species lived, says new research conducted in part...rises to me was that the overall pattern of surviv...than the catastrophic model we were expecting," sa...e and professor in the U of A,s Department of Biol...
...eceptors in breast cancer may play a role in resis...xifen treatment, according to a study in the May 1...Pak 1 is a member of a family of proteins involved...cell movement, and cell death. Previous studies h...y lead to more invasive breast cancer. , Goran ...
...nsible for singing and mating are shrinking when e...of Alberta research--the first proof that natural ...ild animal. , "These residues have been persisti...turbing," said Dr. Andrew Iwaniuk, a post-doctoral...chology. "It has been years since it has been used...
Other Biology News:Tyrannosaur survivorship -- tough times for teens 2Pak1 expression increases tamoxifen resistance in breast cancer patients 2Bird brains shrink from exposure to contaminants 2
(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...-FirstCall/ -- ,, 3Q09 Corporate Highlights:...arketing Authorization to Astellas Pharma Europe L...iness activities Expanded management team to incl...ctor, Commercial Operations Appointed Bradford S....chairman , Upcoming 2009 Milestones: ,...
(Date:11/6/2009)...rowhead’s 2010 Personalized Medicine Partner...bruary 22-24, 2010 in Philadelphia, has been annou...ht key issues in forming partnerships and engage t... Minneapolis, MN (PRWEB) Nove...2010 Personalized Medicine Partnerships Conference...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...ced today,that the company initiated its pivotal P...tucel-L) in the treatment of advanced non-small ce... in the study was treated by,Dr. Lyudmila Bazhenov...sity,of California, San Diego School of Medicine.,...80821/LATH009-a ), (Photo: http://www.newscom.co...
...nderlying Cause of Cystic,Fibrosis; Oral Drug May ...ELD, N.J., Aug. 20 New phase 2 data,published tod...l drug,PTC124 demonstrates activity in nonsense-mu...eatment with PTC124 results in statistically signi...on of patients with,nonsense-mutation CF. The stud...
...ystems,(MMS) today announced a new partnership wit... the result of a legislative initiative that,estab...h benefit for North,Dakota state employees and oth...nce Pharmaceutical Care System(TM) will provide No...aining and technology to guide and,document the de...
Other Biology Technology:NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 2PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 3PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 4PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet 5North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes 2
Silencer Pre-designed siRNA, PAGE purified, annealed from Ambion
...are designed to rapidly and reliably amplify unkno... APAgene provides hassle-free, ready-to use compon... necessary ingredients are provided in each kit. T...t-end amplification of large clones such as P1, YA...
Rabbit Anti-Yaf9 Polyclonal Antibody, Unconjugated from Abcam
...is designed to deparaffinize and perform Heat Indu...affin-embedded tissue sections mounted on glass mi...by melting the paraffin at the high temperature us...ation of the paraffin by detergent. Formaldehyde f...
Biology Products: